Profile

Patricia Y. Fechner, MD

Patricia Y. Fechner, MD

Endocrinology, Disorders of Sex Development

On staff since November 2006

Children's Title: Medical Director, DSD program

Academic Title: Associate Professor, Pediatrics

Research Center: Center for Clinical and Translational Research

Patricia Fechner, MD, is attending physician at Seattle Children’s Hospital and associate professor of pediatrics at the University of Washington School of Medicine. Her clinical and research interests include Turner syndrome, androgen insensitivity syndrome and other disorders of sex determination as well as growth hormone and IGF-1 deficiency. She is associate editor of Sexual Development.

Making A Difference

  • It's a Boy! Or Is It a Girl?

    The Disorders of Sex Development program offers patients the most innovative treatments and guides families as they face some of the most difficult decisions imaginable. ... cont.

Overview

Board Certification(s)

Pediatric Endocrinology
Pediatrics

Medical/Professional School

Northwestern University School of Medicine, Chicago
Massachusetts Institute of Technology, Cambridge

Residency

Pediatrics, University of California Irvine Medical Center, Orange

Fellowship

Pediatric Endocrinology, Johns Hopkins University School of Medicine, Baltimore

Clinical Interests

Sex Determination, Turner Syndrome, AIS, Growth, Puberty

Research Focus Area

Translational Research

Publications

  • Moshiri M, Chapman T, Fechner PY, Dubinsky TJ, Shnorhavorian M, Osman S, Bhargava P, Katz DS
    Evaluation and management of disorders of sex development: multidisciplinary approach to a complex diagnosis.
    Radiographics : a review publication of the Radiological Society of North America, Inc , 2012 Oct. : 32(6)1599-618
  • Chiu HK, Sanda S, Fechner PY, Pihoker C
    Correlation of TSH with the risk of paediatric thyroid carcinoma.
    Clinical endocrinology , 2012 Aug. : 77(2)316-22
  • Adam MP, Fechner PY, Ramsdell LA, Badaru A, Grady RE, Pagon RA, McCauley E, Cheng EY, Parisi MA, Shnorhavorian M
    Ambiguous genitalia: what prenatal genetic testing is practical?
    American journal of medical genetics. Part A , 2012 June : 158A(6)1337-43
  • Davenport ML, Roush J, Liu C, Zagar AJ, Eugster E, Travers S, Fechner PY, Quigley CA
    Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome.
    Hormone research in paediatrics , 2010 July : 23-32
  • Henry RK, Keil MF, Stratakis CA, Fechner PY
    Cushing's syndrome secondary to isolated micronodular adrenocortical disease (iMAD) associated with rapid onset weight gain and negative abdominal MRI findings in a 3 year old male.
    Journal of pediatric endocrinology & metabolism : JPEM , 2010 June : 613-20
  • Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, Gunther DF, Liu C, Geffner ME, Thrailkill K, Huseman C, Zagar AJ, Quigley CA
    Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial.
    The Journal of clinical endocrinology and metabolism , 2007 Sept. : 3406-16
  • Fechner PY, Davenport ML, Qualy RL, Ross JL, Gunther DF, Eugster EA, Huseman C, Zagar AJ, Quigley CA
    Differences in follicle-stimulating hormone secretion between 45,X monosomy Turner syndrome and 45,X/46,XX mosaicism are evident at an early age.
    The Journal of clinical endocrinology and metabolism , 2006 Dec. : 4896-902
  • Leung MY, Steinbach PJ, Bear D, Baxendale V, Fechner PY, Rennert OM, Chan WY
    Biological effect of a novel mutation in the third leucine-rich repeat of human luteinizing hormone receptor.
    Molecular endocrinology (Baltimore, Md.) , 2006 Oct. : 2493-503
  • Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM
    Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome.
    Human reproduction (Oxford, England) , 2006 Jan. : 109-20
  • Fechner PY
    Gender differences in puberty.
    The Journal of adolescent health : official publication of the Society for Adolescent Medicine , 2002 Apr, : 44-8

Presentations

Presentations Title Event Location Date
Outcomes in Congenital Hypothyroidism Parent support group Seattle, WA March 13, 2009

Research Funding

Grant Title Grantor Amount Award Date
Genotropin Mark VII pen Pfizer Sept. 1, 2009
Quality of Life in Intersexuality: A Pediatric Clinical and Research Tool National Institute of Child Health and Human Development May 1, 2009
Efficacy and Safety of Leuprolide Acetate 11.25 and 30 mg formulations Abbott Aug. 28, 2008
Recombinant Human Growth Hormone and Recombinant Human Insulin-like Growth Factor-1 Tercica April 4, 2008
Increlex Growth Forum Database-IGFD Registry: A Patient Registry for Monitoring Long-term Safety and Efficacy of Increlex Tercica Jan. 1, 2007
Effect of Early Growth Hormone Treatment on Long-Term Growth and Skeletal Maturation in Girls with Turner Syndrome Eli Lilly and Company Jan. 1, 2006